Comparison of EQ-5D and SF-6D utilities in Pompe disease

被引:12
|
作者
Kanters, T. A. [1 ,2 ]
Redekop, W. K. [1 ]
Kruijshaar, M. E. [2 ,3 ]
van der Ploeg, A. T. [2 ,3 ]
Rutten-van Molken, M. P. M. H. [1 ]
Hakkaart, L. [1 ]
机构
[1] Erasmus Univ, Inst Med Technol Assessment, Dept Hlth Policy & Management, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC Univ, Med Ctr, Ctr Lysosomal & Metab Dis, NL-3015 GJ Rotterdam, Netherlands
[3] Erasmus MC Univ, Med Ctr Rotterdam, Dept Pediat, Div Metab Dis & Genet, NL-3015 GJ Rotterdam, Netherlands
关键词
Preference-based measure of health; EQ-5D; SF-6D; Orphan disease; Pompe disease; HEALTH; ADULTS; INSTRUMENTS; PROGRESSION; VALIDITY; EUROQOL; IMPACT;
D O I
10.1007/s11136-014-0833-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Comparative studies between Euroqol-5D (EQ-5D) and ShortForm 6D (SF-6D) utilities have been performed for a number of diseases, but not yet for orphan diseases. Pompe disease is an orphan disease with a prevalence of < 5/10,000, characterized by impaired ambulatory and pulmonary functioning. We compared the psychometric properties of EQ-5D and SF-6D in patients with this disease and assessed their convergent validity, discriminative ability and sensitivity to change. EQ-5D utilities and SF-6D utilities were computed using the UK value set. Dimensions and utilities of the two instruments were compared by correlation coefficients and descriptive statistics. We assessed whether EQ-5D and SF-6D were able to discriminate between different levels of severity and examined sensitivity to change for patients with multiple observations. Correlations between theoretically related dimensions of the EQ-5D and SF-6D were highly significant and were moderate to strong (range rho = 0.409-0.564). Utility values derived from the two instruments were similar (mean EQ-5D = 0.670; mean SF-6D = 0.699) and correlated strongly (rho = 0.591). Discriminative properties were somewhat better for EQ-5D; mean changes and effect sizes were better for SF-6D. Overall, we conclude that both instruments appear to be equally appropriate with respect to assessing utilities in Pompe disease, but neither of them performed excellently. The descriptive system of the SF-6D describes health states for Pompe disease more accurately. EQ-5D showed better discriminative properties. The SF-6D performed better with respect to sensitivity to change.
引用
收藏
页码:837 / 844
页数:8
相关论文
共 50 条
  • [41] Mapping the schizophrenia quality of life scale to EQ-5D, HUI3 and SF-6D utility scores in patients with schizophrenia
    Seow, Lee Seng Esmond
    Lau, Jue Hua
    Abdin, Edimansyah
    Verma, Swapna K.
    Tan, Kelvin Bryan
    Subramaniam, Mythily
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (07) : 813 - 821
  • [42] Validation and comparison of EQ-5D-3L and SF-6D instruments in a Spanish Parkinson's disease population sample
    Angel Garcia-Gordillo, Miguel
    del Pozo-Cruz, B.
    Adsuar, J. C.
    Cordero-Ferrera, J. M.
    Abellan-Perpinan, J. M.
    Sanchez-Martinez, F. I.
    NUTRICION HOSPITALARIA, 2015, 32 (06) : 2808 - 2821
  • [43] Using the knee-specific Hughston Clinic Questionnaire, EQ-5D and SF-6D following arthroscopic partial meniscectomy surgery: a comparison of psychometric properties
    Goodwin, Peter C.
    Ratcliffe, Julie
    Morris, Julie
    Morrissey, Matthew C.
    QUALITY OF LIFE RESEARCH, 2011, 20 (09) : 1437 - 1446
  • [44] Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D
    Teckle, Paulos
    McTaggart-Cowan, Helen
    Van der Hoek, Kim
    Chia, Stephen
    Melosky, Barb
    Gelmon, Karen
    Peacock, Stuart
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
  • [45] Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis
    Thaweethamcharoen, Tanita
    Noparatayaporn, Prapaporn
    Sritippayawan, Suchai
    Aiyasanon, Nipa
    VALUE IN HEALTH REGIONAL ISSUES, 2019, 18 : 59 - 64
  • [46] Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain
    Obradovic, Marko
    Lal, Arun
    Liedgens, Hiltrud
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
  • [48] Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease
    Kularatna, Sanjeewa
    Byrnes, Joshua
    Chan, Yih Kai
    Ski, Chantal F.
    Carrington, Melinda
    Thompson, David
    Stewart, Simon
    Scuffham, Paul A.
    QUALITY OF LIFE RESEARCH, 2017, 26 (12) : 3399 - 3408
  • [49] The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes
    Brendan Mulhern
    Keith Meadows
    Health and Quality of Life Outcomes, 12
  • [50] How should we measure the impact of chronic pain? Limitations of utility measurement using the EQ-5D and SF-6D
    Schofield, Deborah J.
    PAIN, 2014, 155 (10) : 1918 - 1919